Why do we need better treatment?

  • Asthma remains a serious health risk in the US;1 moreover, uncontrolled asthma increases unscheduled healthcare visits and hospitalization2 and disrupts daily activities3
  • At least 30% of adherent patients remain symptomatic despite ICS/LABA therapy4–6 and, on average, half of patients on combination therapy still suffer from ≥1 night-time awakenings a week7
  • In patients who remain symptomatic on ICS/LABA, and are being considered for a change in pharmacological therapy, more effective treatment options are needed

Related materials

Webinar graphic

What are the long-term goals of asthma management?

The long-term goals of asthma management are to achieve…

Find Out More

Podcast graphic

What are the key considerations for managing patients with uncontrolled…

Asthma is a heterogeneous disease and its management is multifactorial; many patients often…

Find Out More

Podcast graphic

Which treatments should be considered when patients have inadequately…

More effective asthma treatments are needed as many patients still experience burdensome…

Find Out More

References

  1. Centers for Disease Control and Prevention (CDC). Most recent national asthma data. Last updated March 24, 2020. Accessed June 12, 2020.
  2. Peters SP et al. J Allergy Clin Immunol 2007;119:1454–61.
  3. Mungan D et al. Respir Med. 2018;139:55–64.
  4. Bateman E, et al. Am J Respir Crit Care Med. 2004;170:836-844.
  5. Davis J, et al. J Asthma. 2019;56(3):332–334.
  6. Lin J, et al. Respir Med. 2015;109(1):44–53.
  7. Price D, et al. npj Prim Care Respir Med. 2014;24:14009.

Asthma Forward is a registered trade mark of the GSK group of companies.
©2022 GSK group of companies. All rights reserved.

SE-GBL-FVU-WCNT-200056 | August 2022